Besides, as a neurotrophic drug, the targeting effect of NGF in brain in degenerative neurological diseases such as Alzheimer's disease and Parkinson's disease is significantly impeded by the presence of the blood brain barrier. Here, NGF is linked to early-onset autosomal dominant Alzheimer disease.